by George Papadopoulos | Oct 27, 2020 | ISPOR Values & Outcomes SPOTLIGHT
Our Director, George Papadopoulos, authored the ISPOR, Research Roundup in the September-October 2020 Edition of the Value & Outcomes Spotlight. The articles featured in this issue’s Research Round-Up look at the current state of real-world evidence (RWE)....
by George Papadopoulos | Oct 21, 2020 | Webinars
Free Webinar: 6th Annual Drugs & Devices Australia – Reimbursement Update. Please join us for this free webinar, hosted by Sarah Griffin, Director of MedTechnique Consulting and George Papadopoulos Partner & Director of Lucid Health Consulting as they...
by George Papadopoulos | Sep 7, 2020 | Discount rates and Economic Evaluations
Authors: Hemant Rathi1 and George Papadopoulos2,3 Skyward Analytics Pte. Ltd., Singapore Lucid Heath Consulting Pty. Ltd., Australia University of New South Wales, School of Medicine, Australia Disclaimer: All opinions expressed in the article are personal ...
by George Papadopoulos | Sep 1, 2020 | ISPOR Values & Outcomes SPOTLIGHT
Our Director, George Papadopoulos, authored the ISPOR Research Roundup in the July-August 2020 Edition of the Value & Outcomes Spotlight. George’s article identifies the interface between experimental and behavioural economics and health economics by identifying...
by George Papadopoulos | Jul 1, 2020 | ISPOR Values & Outcomes SPOTLIGHT
Our Director, George Papadopoulos, authored the ISPOR Research Roundup in the May-June 2020 Edition of the Value & Outcomes Spotlight. George’s article identifies recent research publications that highlight innovative pricing models for pharmaceuticals and/or...
Recent Comments